The results of the credit evaluation of pharmaceutical recruitment have come out again, and the companies and varieties involved in bribery have also been announced.

On December 9, the Shandong Provincial Public Resources Trading Center issued the "Announcement on the Pharmaceutical Price and Procurement Credit Evaluation Results of Shenyang Xinma Pharmaceutical Co., Ltd." Guiding Opinions" (Mibaofa [2020] No. 34), "Operating Standards for Pharmaceutical Prices and Recruitment Credit Ratings (2020 Edition)", "Discretionary Benchmarks for Pharmaceutical Prices and Recruitment Credit Ratings (2020 Edition)", Shandong Provincial Public Resources Under the guidance of the Shandong Provincial Medical Insurance Bureau, the trading center conducts credit rating assessments on pharmaceutical prices and behaviors that are inconsistent with good faith in the list of untrustworthy matters in recruitment and procurement.

Along with the announcement, "About Shenyang Xinma Pharmaceutical Co., Ltd. Medicine Price and Recruitment Credit Evaluation Results" was released. The content showed that the type of untrustworthy behavior was "giving kickbacks to various medical institutions at all levels, centralized purchasing agencies and their staff in the purchase and sale of medicines." or other improper interests", the product involved is ambroxol hydrochloride.

On September 16, 2020, the National Medical Insurance Administration issued the "Guiding Opinions on Establishing a Pharmaceutical Price and Procurement Credit Evaluation System", requiring provincial centralized procurement agencies to take written reminders and warnings based on the credit ratings of pharmaceutical companies and rely on centralized procurement platforms to If the purchaser prompts risk information, restricts or suspends the listing of relevant drugs or medical consumables, restricts or suspends the purchase of relevant drugs or medical consumables, discloses information about dishonesty, and other disposal measures, if the number of provinces involved in the dishonesty reaches the prescribed conditions, the National Medical Security Administration shall The Price and Bidding Procurement Guidance Center launched a national joint disposal.

In accordance with the "Operation Standards for Pharmaceutical Price and Procurement Credit Evaluation (2020 Edition)", provincial centralized procurement agencies carry out pharmaceutical price and procurement credit evaluation work, mainly relying on the facts of dishonesty determined by court judgments and departmental administrative penalties. They are not responsible for Investigate, characterize and deal with illegal activities such as pharmaceutical kickbacks.

For the type of breach of trust in this case, the starting time of the statute of limitations is calculated from the effective date of the court judgment or the administrative penalty decision of the relevant law enforcement department. The court judgment shall be based on the effective date of the first instance judgment. It can be seen that the statute of limitations starts and ends this time for three years, until June 24, 2027.

https://mp.weixin.qq.com/